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Objective: This study was designed to evaluate how various sizes and densities of
pores in Dacron tubing might enhance its utility as a tracheal prosthesis.
Methods: A vascular prosthesis made of knitted external velour polyester was
prepared for pore formation with a laser. The first set compared different pore sizes
(300, 500, and 700 m) and pore densities (25/cm2 or 100/cm2). Grafts were
reinforced with an externally heat-sealed silicone ring. The second set tested grafts
with a pore density of 64/cm2 and a pore size of 500 m internally reinforced with
a stainless-steel spiral stent. In all experiments, a canine mediastinal trachea 10
cartilage rings in length was resected, and the prosthesis was then implanted with an
omental flap.
Results: Lower pore size and density (300 m, 25 pores/cm2) led to essentially no
tissue ingrowth. Larger pore size (700 m) and low density (25 pores/cm2) led to
rapid and excessive ingrowth of granulation. Midrange pore size (500 m) and high
density (100 pores/cm2) invited steady tissue ingrowth, but marked luminal stenosis
eventually developed. Stent-reinforced prostheses with 500-m pores at 64 pores/
cm2, as used in the second set, maintained an average patency rate of 60% or more
(range, 20%-100%) at least 12 months after implantation.
Conclusion: Our data show that porosity is a key factor for tissue growth through our
Dacron tracheal prostheses. This artificial trachea model has led to long-term
survivors up to 27 months after the operation and seems promising as a basic model
for clinical tracheal repair.
Avariety of tracheal prostheses have been reported,1 but an idealmodel has to be refined for safe and durable practical use. Themost common causes of graft failure include anastomotic stenosis,luminal stenosis, infection, dislocation, and migration.Our laboratory has previously tested and reported a 5-cm-longnonporous type of artificial trachea made of a knitted Dacron tube
that was internally coated with silicone except for 5 mm at each end, which was to
be reserved for anastomoses.2-5 We also tested the effects of hepatocyte growth
factor and cultured fibroblasts to go with the abovementioned model to replace the
mediastinal trachea in dogs. Although some of the dogs survived for more than a
year after the operation in fair condition, anastomotic stenosis prevented most dogs
from being long-term survivors.
On the other hand, from what had been reported by others, early tissue coverage
and epithelialization of the internal surface of the graft is believed to prevent
stenosis of the grafts in cases using porous-type artificial tracheas. Optimal graft
porosity has been reported regarding other types of materials but not Dacron. This
provided a motivation for us to test how porosity works in the Dacron tracheal graft
models. This study is divided into 2 sections. The first set of experiments was
designed to identify an optimal pore diameter and pore density to be used in a Dacron
tube tracheal graft. The second aspect of this study focused on the application of the
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optimal pore size and density thus obtained to our artificial




A straight vascular prosthesis, 5 cm long and 16 mm in diam-
eter, made of knitted external velour polyester (MICRON, Inter
Vascular) was used with an internal mechanical support. Initial
porosity of this material was 1200 mL · cm2 · min. Pores were
created in the structure by using a laser ablation technique. The
first set of grafts served to determine the optimal pore size and
density for conditioned tissue ingrowth. Pore sizes of 300, 500,
or 700 m were generated with pore densities of either 25/cm2
or 100/cm2. Grafts were reinforced in this set with 1.5-mm-
wide heat-sealable silicone rings (Figure 1, A). The second set
of grafts were made with 500-m pores at a density of 64
pores/cm2 but reinforced with a 0.4-mm-diameter spiral stent
made of stainless steel (Figure 1, B and C). Pore density was set
at 64 pores/cm2 depending on the results of the first set of
experiments and also for technical reasons, meaning a midrange
density of between 25 and 100 pores/cm2. Laser ablation tech-
nology, heat-sealable silicone, and stainless-steel spiral stents
were obtained from Koken Co, Ltd. Each graft was finally
coated with fibrin glue (Beriplast P, Aventis Behring) just
before the operation to prevent air leakage.
Implantation
Fifteen mongrel dogs weighing 14 to 16 kg were anesthetized with
pentobarbital sodium (4 mg/kg), intubated endotracheally, and
administered GO by means of a ventilator (Mear/ADV-1000MK
II, Senko Ika Kogyo). With each dog in the supine position, an
upper median abdominal incision was made. An omental flap was
prepared, including the right gastroepiploic artery. The abdomen
was temporarily closed, and a right thoracotomy was performed
through the fourth intercostal space, with the dog in the left lateral
position. The mediastinal trachea was exposed and resected at a
length of 10 cartilaginous rings, whereas the left lung was venti-
lated through the second endotracheal tube placed through the
operative field (Figure 2).
The artificial tracheal graft was then implanted by using end-
to-end anastomoses with 4-0 nonabsorbable running sutures (Ethi-
bond Excel, Ethicon). After the anastomoses were completed, the
abdominal incision was reopened, with the dog kept in the lateral
position. The previously made omental flap was introduced into
the right chest cavity through a slit made in the right hemidia-
phragm. The entire graft was then wrapped with the pedicled
omental flap. The chest and abdominal wounds were finally closed
in layers, and the thoracostomy tube was removed immediately
after closing the wound.
Postoperatively, each dog was allowed to recover spontane-
ously. A 500-mg intramuscular dose of kanamycin was given on
the day of operation and on postoperative day 1.
Figure 1. A, The Dacron tracheal prosthesis reinforced with heat-sealed silicone rings. B, The Dacron prosthesis
with 500-m pores at a density of 64 pores/cm2. C, Spiral stainless-steel stent inserted in the Dacron prosthesis.
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Conventional Bronchoscopic and Histologic
Examinations
A bronchoscope (model BF1T30 or BF200, Olympus Optical Co
Ltd) was applied at 2 weeks and every month thereafter during
intravenous pentobarbital sodium anesthesia through an endotra-
cheal tube. We observed the degree of tissue ingrowth and the
patency rate of the graft, and we also histologically examined the
degree of epithelialization on the internal surface of the ingrown
tissue by means of punch biopsy. Biopsy specimens were fixed in
10% phosphate-buffered formalin, embedded in paraffin, and sec-
tioned. Sections were stained with hematoxylin and eosin. The
patency rate was calculated by dividing the internal cut surface
area of the central portion of the graft by the native tracheal cut
surface area on bronchoscopic views.
Magnifying Bronchoscopic Examination
A magnifying bronchoscope (XBF-200HM, Olympus Optical Co
Ltd) was used to examine the internal surface of the graft at 12 to
27 months during intravenous pentobarbital sodium anesthesia
through an endotracheal tube. Ingrown vessels within the tissue on
the inner surface of the graft were observed in vivo, and magnified
pictures were obtained.
Figure 3. Bronchoscopic view of the reconstructed trachea. A, Ingrown tissue was limited by heat-sealed silicone
rings in the preliminary experiment series. B, Good luminal patency and full-tissue coverage of the prosthesis were
observed at 21 months after implantation in the second experimental series.
Figure 2. Implantation of the Dacron prosthesis in a dog. A, Caudal anastomosis was performed with a second
endotracheal tube inserted through the operative field. B, The entire prosthesis was wrapped by the omental flap.
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Animals were killed with an injected overdose of sodium pento-
barbital if intraluminal patency rates, anastomotic patency rates, or
both decreased to less than 10%.
All animals received humane care in compliance with the
“Principles of Laboratory Animals Care” formulated by the Na-
tional Society for Medical Research and the “Guide for the Care
and Use of Laboratory Animals” prepared by the National Acad-
emy of Science and published by the National Institutes of Health
(publication no. 85-23, revised 1985).
Results
Patency of the Implanted Grafts Seen by Means of
Conventional Bronchoscopic Examinations
Results are summarized in Table 1. All dogs tolerated the
surgical procedure well, and perioperative mortality oc-
curred only in dog 5, which died of ileus 3 days after the
operation.
In the first set of experiments, it was seen that smaller
pores (300 m) and lower density (25 pores/cm2) led es-
sentially to no tissue ingrowth, whereas larger pores (700
m) and low density (25 pores/cm2) led to a rapid and
excessive ingrowth of granulation tissue through the pores,
with the ingrown tissue not uniformly covering the internal
surface. Ingrowth was apparently disturbed at those pores
incidentally occluded by the heat-sealed silicone rings (Fig-
ure 3, A). Although moderate pore size (500 m) and high
density (100 pores/cm2) led to tissue ingrowth over the
entire prosthesis, the lumen, however, exhibited marked
stenosis by 2 months after the operation.
The second set of experiments was based on the results
of the first set experiments. Pores 500 m in size with a
density of 64 pores/cm2 were expected to bring about a
moderate amount but evenly distributed ingrowth on tissue
on the inner surface of the grafts. Intraluminal patency rates
of the grafts as of the second study are shown in Figure 4
with their time course. Dogs 10, 12, 13, 14, and 15 actually
maintained an average patency rate at 60% or more (ranging
from 20%-100%) up to 12 months after implantation (Fig-
ure 3, B). Conventional bronchoscopy revealed complete
coverage of the inner surface of the graft with ingrown
tissue by 3 months after implantation in 4 of 6 dogs.
Dog 10 has survived in a good condition without any
remarkable stenosis of the graft for greater than 27 months
after implantation. In dogs 10 and 14 conventional bron-
choscopy revealed patchy areas left apparently uncovered
by ingrown tissue on the inner surface of the graft 18 and 27
months after implantation, respectively, although no graft
infection was seen.
Histologic Examinations
All dogs except dog 7 had the appearance of an epithelial
cell lining on the inner surface, as confirmed on the basis
of biopsy specimens taken from the ingrown tissue be-
tween 1 and 3 months after implantation (Figure 5, A).
The graft harvested from dog 11 showed body stenosis by
overgrowing whitish-colored tissue. This thick, almost
scarring tissue also possessed an epithelial lining (Figure
5, B and C).
Magnifying Bronchoscopic Examination
A submucosal network of blood vessels was observed,
extending from the native submucosal vessels across the
anastomoses inward toward the inner surface of the graft for
up to 1 cm in distance. These vessels ranged from 8 to 300
m in diameter. In the central part of the prosthesis, vessels
were observed coming through the pores, presumably orig-
inating in the omental flap. A fine, tiny vascular network
was also observed, even in the area in which no ingrown
















1 300 25 None None Anastomosis 15 Killed
2 500 25 Part 0.5 Anastomosis 14 Died
3 500 25 Part 0.5 Luminal 3 Killed
4 500 100 Entire at 1 mo 1 Luminal 2 Killed
5 500 100 Entire at 1 mo 1 Anastomosis 2 Killed
6 700 25 Part 0.5 Anastomosis 5 Killed
7 700 25 Part 2 Anastomosis 11 Killed
8 700 25 Part 0.5 Anastomosis 26 Killed
9 700 25 Part — — 3 days Died (ileus)
10 500 64 Part None None 27 Alive
11 500 64 Entire at 1 mo 1 Luminal 20 Killed
12 500 64 Entire at 1 mo 2 Luminal 24 Alive
13 500 64 Entire at 2 mo None Luminal 24 Alive
14 500 64 Part 12 Luminal 19 Alive
15 500 64 Entire at 3 mo 1 Luminal 17 Alive
General Thoracic Surgery Tsukada and Osada
880 The Journal of Thoracic and Cardiovascular Surgery ● March 2004
G
TS
tissue was observed by means of conventional bronchos-
copy (Figure 6).
Discussion
Developing suitable materials and models for reconstructing
the trachea has been an attractive area of thoracic surgery
research for more than 50 years. A number of approaches to
tracheal reconstruction have been reported. There have been
autografts,6 allografts,7 xenografts,8 tissue-engineered
grafts,9 grafts made of prosthetic materials,1 and combina-
tions of these grafts.3-5 Each approach encountered limited
success. We focused on prosthetic materials, aiming at
easier clinical application.
Earlier in 1967, Graziano and associates10 reported on
bifurcated semirigid synthetic polydimethyl siloxane grafts
in canines. After this, Neville and associates11 evaluated a
silicone nonporous-type prosthesis rimmed with Dacron in
62 clinical cases. Neville and coworkers12 observed that the
prosthesis was rapidly incorporated into the surrounding
tissue within the mediastinum but was unable to develop an
epithelial bridging over the inner surface of the prosthesis.
Neville and associates11 claimed that ciliated epithelial lin-
ing of the prosthesis was not essential.
Pearson and colleagues13 evaluated a heavy, porous Mar-
lex mesh prosthesis and observed a thin layer of granulation
tissue penetrating the graft through the pores within 6 weeks
postoperatively. This model was abandoned because of fre-
quent occurrence of innominate artery erosion in clinical
use. In 1994, Okamura and associates14 evaluated the col-
lagen-conjugated fine Marlex mesh prosthesis and observed
epithelial lining on the prosthetic inner surface with good
biocompability. This report evolved our hypothesis and led
to the evaluation of our present porous model. We also
believe that an earlier ingrowth of tissue along with epithe-
lialization led to a successful tracheal graft.
In the present study we chose Dacron as the material
because of its good tissue compatibility and widespread
clinical use. The native porosity of Dacron, however, does
not seem sufficient for inviting tissue ingrowth. There have
been no studies with Dacron as a modified porous material
for circumferential tracheobronchial reconstruction. Kai-
ser15 reported that a 2  2–cm defect of canine cervical
trachea was closed with a Dacron patch having a porosity of
25 to 50 m or 125 to 150 m. He observed that the
smaller-pored Dacron patch was rejected, and the larger-
pored patch was covered by connective tissue as quickly as
90 days after the operation. Shimizu and associates16 re-
ported an optimal pore size of fine Marlex mesh, approxi-
mately 300 m, for a patch graft to the cervical trachea in
dogs. Nelson and colleagues17 worked on bioelectric poly-
urethane and reported 60- to 120-m pores as suitable for a
mediastinal tracheal graft with an omental flap in dog mod-
els. Jorge and coworkers18 reported an optimal pore size of
30 m in an expanded polytetrafluoroethylene prosthesis
reinforced with spiral silicone rings implanted to cervical
circumferential defects in rabbit models. They observed 3 of
10 animals having intraluminal hypertrophic granulation
tissue 1 month after the operation. The suitable pore size
seems to vary greatly depending on the animal model,
material, and prosthetic model used in relation to the sur-
rounding host tissue. We concluded in this series that opti-
mal pore size was 500 m along with a pore density of
64/cm2.
Rigidity of the prosthesis is another important issue. A
tube made of wire mesh, Teflon, or silicone might maintain
the patency to some extent by means of its own mechanical
rigidity. Stiffer materials might tend to cause erosion of
neighboring great vessels in the mediastinum. This compli-
cation is potentially avoidable by inserting a muscle flap or
pericardial flap between the prosthesis and the vessels.
Alternative soft material could not maintain an open airway.
We first reinforced the porous Dacron prosthesis from the
outside by heat sealing it with 1.5-mm silicone rings in a
spiral pattern. This worked well to prevent airway collapse
Figure 4. Intraluminal patency rates of the main experiment group.
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but partially prevented tissue ingrowth. We therefore
changed the stenting model to use a spiral stainless-steel
stent applied from inside to prevent collapse. This stent did
not obstruct the pores and led to rapid and relatively uni-
form tissue ingrowth. It should be mentioned that back in
1950, Belsey19 reported the first successful circumferential
replacement of a human intrathoracic trachea. Belsey used a
composite prosthesis with a steel spring covered with fascia
lata. Surprisingly, the steel wire was completely covered
with regenerated ciliated epithelium and completely embed-
ded in the wall of the trachea 1 year after implantation. In
the present study the stainless-steel stent also became em-
bedded in the ingrown granulation tissue as early as 2 weeks
after the operation. Dog 11 showed shortening in the length
of the prosthesis caused by accordion-like prosthetic shrink-
age, which subsequently caused luminal stenosis. The spiral
configuration of the stent was therefore one of the causes of
prosthetic stenosis. Further reinforcement or modification of
the spiral stent would likely resolve this problem.
Figure 5. Histologic examination. A, A specimen taken from the internal tissue revealing ciliated cells at 1 month
after the implantation. B, Longitudinal section of the prosthesis 21 months after the implantation: the luminal
surface was covered by smooth thick white tissue. C, Ciliated epithelial cells lined on thick fibrous tissue.
Figure 6. Magnifying bronchoscopic view revealing a fine vas-
cular network on the Dacron prosthesis.
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We do believe that the lining epithelium came from both
ends of the native trachea onto the inner surface of the graft.
Epithelial lining on granulation tissue was present between
1 and 3 months after the operation. Pearson and associates13
reported that further proliferation of granulation tissue
ceased along with the surface epithelialization after the
operation. In our present series, however, an early intralu-
minal stenosis occurred in these 2 dogs as a result of
excessive tissue ingrowth, despite epithelialization. Possibly
a continuous foreign body reaction against Dacron had an
edge on the conditioning function of the epithelial cells.
This phenomenon raises a need to do further research.
The omentum has been recognized as clinically useful
when applied to the intrathoracic structure,20 and the omen-
tum is well known to have an immunologic protective
ability. One of the most important functions of the omentum
is releasing angiogenic factors. Angiogenic factors activate
the milky-spot macrophages, causing new capillaries to
sprout and invade the fibrous network.21 Zhang and cowork-
ers22 reported that the omentum demonstrated the highest
vascular endothelial growth factor secretion rate, as well as
the highest concentration of vascular endothelial growth
factor protein of the various rat tissues and organs exam-
ined. The omentum seems to be the best wrapping for
autologous tissue to prevent air leakage, as well as graft
infection, and leads to early granulation tissue. Nelson and
associates17 indeed reported a stable healing process of
tracheal prostheses by using omental-wrapping techniques.
Teramachi and coworkers23 reported plenty of vessels in the
regenerated mucosa of a collagen-coated Marlex mesh tra-
cheal prosthesis after omentoplasty 3 to 6 months after
implantation. They speculated that the vessels declined after
complete intraluminal epithelialization of the inner surface.
Neovascularity of the ingrown tissue is another impor-
tant issue to discuss. Nelson and associates17 reported de-
tails of neovascularity in tracheal prostheses in the medias-
tinal trachea with omental flap in dog models by using the
barium suspension angiographic ex vivo technique. Magni-
fying bronchoscopy is a new technology developed by
Olympus Optical Co Ltd. This scope makes it possible to
perform real-time in vivo observation of small-sized vessels
greater than 8 m in diameter. Generally, artificial materials
are a hotbed for infection in a living body, especially in the
airway because it is directly exposed to the outer environ-
ment. Two of the dogs in our second set had large areas of
their grafts apparently uncovered by any tissue, as deter-
mined with a conventional bronchoscope. Neither animal,
however, became infected, even beyond 18 to 27 months.
We observed, in these areas, a fine network of vessels
through pores of Dacron prostheses in these apparently
uncovered areas by using the magnifying bronchoscope. We
believe that the presence of a vessel network with a thin
layer of tissue was protecting the graft from infection.
It is widely recognized that native tissue is preferable in
reconstructing the tracheobronchial tree. Recently, Kojima
and associates9 have tried to produce a tracheal prosthesis
model made of purely autologous cultured chondrocytes.
They evaluated an autologous tissue-engineered trachea by
replacing a 5-cm defect of the sheep cervical trachea. The
tissue-engineered trachea looked almost indistinguishable
from native tissue. The histology of the tissue-engineered
trachea and native trachea was also similar. Because of the
lack of rigidity, however, that model has not been able to
sustain patency for a long period. Animals died in 2 to 7
days as a result of malacia and stenosis. In addition, the time
needed to generate a tissue-engineered trachea limits its
applications for clinical use.
In conclusion, our data show that our Dacron tube with
500-m pores and a density of 64 pores/cm2 worked well
up to 27 months after the operation. Only one of 6 dogs had
intraluminal stenosis at the body of the graft. Epithelializa-
tion with ciliated cells appeared 1 to 2 months after implan-
tation. A fine vascular network was observed when exam-
ined with a magnifying bronchoscope, even in portions
apparently uncovered, as determined with a conventional
bronchoscope. This artificial trachea model has led to long-
term survivors and seems promising as a basic model for the
clinical setting of tracheal repair.
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